clodronic acid has been researched along with Bright Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Apostolopoulos, J; D'Souza, M; Holdsworth, SR; Huang, XR; Milton, G; Oettinger, C; Tipping, PG | 1 |
D'Souza, MJ; Huang, XR; Milton, GV; Oettinger, CW; Shah, A; Tipping, PG | 1 |
2 other study(ies) available for clodronic acid and Bright Disease
Article | Year |
---|---|
Mechanisms of T cell-induced glomerular injury in anti-glomerular basement membrane (GBM) glomerulonephritis in rats.
Topics: Animals; Antibodies, Blocking; Apoptosis; Basement Membrane; CD4 Antigens; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Movement; Clodronic Acid; Complement System Proteins; DNA; Glomerulonephritis; Immunoglobulins; Kidney Glomerulus; Killer Cells, Natural; Lymphocyte Depletion; Macrophages; Male; Proteinuria; Rats; Rats, Sprague-Dawley; T-Lymphocytes | 1997 |
Macrophage depletion by albumin microencapsulated clodronate: attenuation of cytokine release in macrophage-dependent glomerulonephritis.
Topics: Albumins; Animals; Clodronic Acid; Glomerulonephritis; Interleukin-1; Macrophages; Microspheres; Rats; Rats, Inbred F344; Tumor Necrosis Factor-alpha | 1999 |